: WHAT: The Federal Trade Commission and the Justice Department’s Antitrust Division, along with the Department of Commerce and the Department of Health and Human Services, will jointly host the first of three listening sessions focused on discussing ways to make prescription drugs more affordable for Americans by promoting competition. The first listening session will discuss anticompetitive conduct that impedes generic or biosimilar competition. WHEN: Monday, June 30, 2025, 2 pm E.T. WHERE: Attendance in-person is by invitation only, but the event is being streamed online . Members of the public may submit questions online . WHO: The listening session will feature remarks by practitioners and
: As part of implementing President Trump’s Executive Order No. 14273, Lowering Drug Prices by Once Again Putting Americans First , the Federal Trade Commission and the Justice Department’s Antitrust Division, along with the Department of Commerce and the Department of Health and Human Services, will jointly host listening sessions to discuss ways to make prescription drugs more affordable for Americans by promoting competition. The three listening sessions will occur under the direction of FTC Chairman Andrew N. Ferguson and Assistant Attorney General Gail Slater of the DOJ Antitrust Division. The listening sessions will focus on improving the affordability of pharmaceuticals by increasing generic and biosimilar availability and promoting competition through drug formularies and benefits. The sessions, which will feature remarks by practitioners and scholars, will cover anticompetitive practices as well as eliminating regulatory barriers and rent seeking . The listening sessions will inform the FTC and DOJ’s [...]